Clinical Trials Directory

Trials / Completed

CompletedNCT01062438

Studying DNA in Tumor Tissue Samples From Patients With Localized or Metastatic Osteosarcoma

Genomic Study of Metastatic Osteosarcoma Using Next-Generation Sequencing Technology

Status
Completed
Phase
Study type
Observational
Enrollment
99 (actual)
Sponsor
Children's Oncology Group · Network
Sex
All
Age
Healthy volunteers
Not accepted

Summary

RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is looking at DNA in tumor tissue samples from patients with localized or metastatic osteosarcoma.

Detailed description

OBJECTIVES: * Determine the genomic expression profile in tumor tissue samples from patients with localized or metastatic osteosarcoma using transcriptome sequencing. * Identify activating and loss of function mutations and gene rearrangement in these tumor tissue samples using transcriptome sequencing. * Identify candidate genes that are important in osteosarcoma and tumorigenesis using genome partition strategies for genomic DNA sequencing. * Identify which mutations are associated with outcome. * Establish which mutations are also found in germ line DNA that predispose the patient to osteosarcoma. OUTLINE: DNA and RNA from banked tumor tissue samples and DNA from paired blood samples are analyzed in sequencing studies using next-generation sequencing technology. The sequencing data from these tumor samples are matched to the Human RefSeq (for transcriptome sequencing) and normal human genome in the public databases and to the patient's germ line sequence to identify constitutional and somatic mutations. Clinical information that is associated with each sample (i.e., age, tumor site, size, primary metastases, response to chemotherapy, surgical remission, follow-up time, and treatment protocol) is also collected, if available.

Conditions

Interventions

TypeNameDescription
GENETICDNA analysis
GENETICRNA analysis
GENETICgene expression analysis
GENETICgene rearrangement analysis
GENETICmutation analysis
OTHERlaboratory biomarker analysis

Timeline

Start date
2010-01-01
Primary completion
2011-09-01
Completion
2011-09-01
First posted
2010-02-04
Last updated
2015-05-06

Source: ClinicalTrials.gov record NCT01062438. Inclusion in this directory is not an endorsement.